Extended-release naltrexone initiated after just five to seven days of seeking treatment is more effective than starting treatment after the traditional interim stage of 10 to 15 days.
Columbia psychologist Erin K. Engle discusses the signs that indicate the time is right to stop therapy and questions patients should ask themselves before moving on.
A P&S research team has found that deficits seen in schizophrenia may be due to a decrease in the number of inhibitory neurons within the brain's memory center.
The Department of Psychiatry's Reiner Center, located on the fifteenth floor of Presbyterian Hospital, opened with a ribbon-cutting ceremony this week.
Increased connectivity in the brain's default mode network is a potential precursor, or biomarker, indicating a risk of developing major depressive disorder.
A new Mailman study examines the separate effects of clinical symptoms and labeling on stigma in young people identified as at risk for psychotic disorders.
Deborah Hasin finds that marijuana use has doubled in the United States, and with the increase comes more marijuana use disorders and cannabis-related accidents.